ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,584.54
      -0.88%
      US Tech 100
      19,660.00
      -2.28%
      Dow Jones
      39,753.75
      0.08%
      Brent Oil
      85.09
      0.05%
      Bitcoin
      57,327.49
      -0.74%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. IDEAYA Biosciences Inc (IDYA)

      7. IDEAYA Biosciences Inc (IDYA) News

      IDYA

      IDEAYA Biosciences (IDYA)

      IDEAYA Biosciences Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:IDYA
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      07/11/20244:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IDYAIDEAYA Biosciences Inc
      07/11/20244:05PMPR Newswire (US)IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional SharesNASDAQ:IDYAIDEAYA Biosciences Inc
      07/10/20245:17PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IDYAIDEAYA Biosciences Inc
      07/09/202410:26PMPR Newswire (US)IDEAYA Announces Pricing of Public OfferingNASDAQ:IDYAIDEAYA Biosciences Inc
      07/09/20245:08PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IDYAIDEAYA Biosciences Inc
      07/09/20244:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IDYAIDEAYA Biosciences Inc
      07/09/20244:08PMPR Newswire (US)IDEAYA Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:IDYAIDEAYA Biosciences Inc
      07/08/20246:37AMIH Market NewsParamount-Skydance $28B Merger, Boeing Agrees to Plead Guilty with $243.6M Fine, and More NewsNASDAQ:IDYAIDEAYA Biosciences Inc
      07/08/20246:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IDYAIDEAYA Biosciences Inc
      07/08/20246:00AMPR Newswire (US)IDEAYA Announces Positive Interim Phase 2 Monotherapy Expansion Data for IDE397 a Potential First-in-Class MAT2A Inhibitor in MTAP-Deletion Urothelial and Lung CancerNASDAQ:IDYAIDEAYA Biosciences Inc
      07/05/20244:05PMPR Newswire (US)IDEAYA Announces Investor Webcast to Report Clinical Data Update for IDE397 Phase 2 Monotherapy Expansion Dose in MTAP-Deletion Urothelial and Lung Cancer on Monday, July 8, 2024NASDAQ:IDYAIDEAYA Biosciences Inc
      06/28/20246:00AMPR Newswire (US)IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IDYAIDEAYA Biosciences Inc
      06/25/20246:00AMPR Newswire (US)IDEAYA Biosciences Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE397 and Trodelvy® Combination in MTAP-Deletion Bladder CancerNASDAQ:IDYAIDEAYA Biosciences Inc
      06/24/20246:00AMPR Newswire (US)IDEAYA Biosciences Announces Clinical Program Updates for IDE397 a Potential First-in-Class Phase 2 MAT2A Inhibitor Targeting MTAP-Deletion Solid TumorsNASDAQ:IDYAIDEAYA Biosciences Inc
      06/03/20246:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IDYAIDEAYA Biosciences Inc
      06/03/20246:00AMPR Newswire (US)IDEAYA Announces Results for Darovasertib Phase 2 IST in Neoadjuvant Uveal Melanoma at ASCO and Clinical Update for Phase 2 Company-Sponsored Neoadjuvant StudyNASDAQ:IDYAIDEAYA Biosciences Inc
      05/31/20244:54PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IDYAIDEAYA Biosciences Inc
      05/31/20244:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDYAIDEAYA Biosciences Inc
      05/31/20244:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDYAIDEAYA Biosciences Inc
      05/31/20246:00AMPR Newswire (US)IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IDYAIDEAYA Biosciences Inc
      05/29/20245:02PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IDYAIDEAYA Biosciences Inc
      05/29/20246:00AMPR Newswire (US)IDEAYA Biosciences to Participate in Upcoming June 2024 Investor Relations EventsNASDAQ:IDYAIDEAYA Biosciences Inc
      05/28/20246:00AMPR Newswire (US)IDEAYA Biosciences Appoints Daniel A. Simon as Chief Business Officer to Lead Corporate Strategy and Business DevelopmentNASDAQ:IDYAIDEAYA Biosciences Inc
      05/23/20249:21PMPR Newswire (US)/C O R R E C T I O N -- IDEAYA Biosciences, Inc./NASDAQ:IDYAIDEAYA Biosciences Inc
      05/23/20245:05PMPR Newswire (US)IDEAYA Biosciences Announces Abstract Summary Results of ASCO 2024 Oral Presentation for Phase 2 Investigator Sponsored Study of Darovasertib in Neoadjuvant Uveal MelanomaNASDAQ:IDYAIDEAYA Biosciences Inc
      05/07/20246:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IDYAIDEAYA Biosciences Inc
      05/07/20246:00AMPR Newswire (US)IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:IDYAIDEAYA Biosciences Inc
      05/01/20246:00AMPR Newswire (US)IDEAYA Biosciences to Participate in Upcoming May 2024 Investor Relations EventNASDAQ:IDYAIDEAYA Biosciences Inc
      04/26/20246:00AMPR Newswire (US)IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IDYAIDEAYA Biosciences Inc
       Showing the most relevant articles for your search:NASDAQ:IDYA